ClinicalTrials.Veeva

Menu

Austrian Left Atrial Appendage Closure Registry

M

Medical University of Graz

Status

Enrolling

Conditions

Atrial Fibrillation
Left Atrial Appendage Closure

Treatments

Device: LAAC

Study type

Observational

Funder types

Other

Identifiers

NCT03409159
29-355 ex 16/17

Details and patient eligibility

About

Left atrial appendage (LAA) occlusion (LAAC) has been introduced to treat patients with indication of oral anticoagulation (OAC) for atrial fibrillation (AF) with contraindication to OAC. This registry aims to document all LAAC procedures in Austria.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who received LAAC in Austria

Exclusion criteria

  • Absence of informed consent

Trial contacts and locations

1

Loading...

Central trial contact

Daniel Scherr, Assoc.Prof. PD Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems